最高の全身MRI検査医師 - トップ49名の医師

ブルント・カラゲズ博士は、トルコのトップ医療腫瘍学者であり、肉腫、リンパ腫、膵臓、肺がんの専門家であり、乳がん外科の医師で、20年以上の経験を持ちます。彼の主なサブスペシャリティは、腫瘍生物学、腫瘍免疫学、がん免疫療法、標的療法です。

職務経験

• 2019年から — アナドル医療センターの医療腫瘍学者
• 2019年 — イスタンブールオカン大学医学部の内科部長、内科および医療腫瘍学部門の部門長および医学倫理委員会の委員長
• 2017-2019年 — GATA ハイダルパシャトレーニング病院の内科の医療腫瘍学部門の部門長
• 2012-2017年 — GATA ハイダルパシャトレーニング病院の内科の医療腫瘍学部セクションの責任者
• 2003年 — チョルル兵士病院の内科医
• 2001年 — NATO の NATO KFOR コマンド
• 1993-1995年 — トルコ系キプロス和平部隊の司令部。

教育

• 1992年 — ギュルハネ軍医科大学 — 一般医学の学位
• 1999年 — GATA ハイダルパシャトレーニング病院 — 内科の専門
• 2006年 — GATA ハイダルパシャトレーニング病院 — 医療腫瘍学の専門。

教育活動

• 2017年 — イスタンブールオカン大学医学部の教授。

科学活動

がん研究で40を超える出版物を執筆しています。

会員資格

• トルコ医療腫瘍学協会

ヨーロッパ頭頸部協会

コース参加

• 腫瘍生物学コース、医療腫瘍学協会、2003年。
• フローサイトメトリートレーニング、イスタンブール大学 (DETAE)、2004年。
• 基本的な疫学（健康における研究手法と分析技術）コース、GATA コマンド、2005年。
• 臨床研究における倫理的アプローチコース、厚生労働省医薬品局および薬局の総局、2009年および2017年（2回）。

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Full time doctor at PrimeCare Bangkok who is also currently pursing a masters degree and research in anti-aging 

Education

Doctor of Medicine (M.D.) degree from Faculty of Medicine, Ramathibodi Hospital, Mahidol University,2023

Certifications

Currently pursuing a Master’s degree in Anti-Aging and Regenerative Medicine, Dhurakij Pundit University Bangkok (DPU)

Languages spoken: English and Thai

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Prof. Dr. Önder SÜRGİT is a General Surgeon in the General Surgery Clinic. Working hours: 09:00–18:00. Core practice areas include laparoscopic surgery, cancer surgery, and bariatric surgery.

Graduated from Hacettepe Faculty of Medicine in 1995. Academic title: Professor. Served as Instructor Surgeon at ITEM (Advanced Medical Technologies Training Center). Held faculty roles at Turgut Özal University and Atılım University, Faculties of Medicine. Also worked at Ankara Medicana Hospital and Optimed Health Group. Foreign language: English.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Oktay Karadeniz, MD, is a radiologist. He graduated from Hacettepe University Medical School in 1992. He completed specialty training in Radiodiagnostics at Göztepe Training and Research Hospital in 1999. He worked at Memorial Hospital from 1999 to 2005. He has been a radiologist at Anadolu Medical Center since 2005.

Clinical focus: musculoskeletal imaging; cardiovascular imaging; oncologic imaging; neuroradiology. Professional memberships: Turkish Radiology Society; Turkish Society of Magnetic Resonance Imaging; International Society for Magnetic Resonance in Medicine; European Society for Magnetic Resonance in Medicine and Biology; American College of Radiology; European Society of Radiology.

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

シボレト博士は、50年以上の実践経験を持つイスラエルのトップの消化器病専門医であり、血液学者です。彼はイヒロヴ医療センターのデータによれば、イスラエルの肝臓の専門家として知られています。

専門分野

オレン・シボレト博士の主な専門分野は肝疾患の治療です。彼は、慢性肝炎や自己免疫、遺伝性肝疾患のような重篤な場合でも、肝臓のあらゆる病理の治療と診断を提供しています。

職務経歴

• スルアスキ（イヒロヴ）医療センターの肝臓科の責任者。

学歴

• ヘブライ大学医学部 — 一般医学の学位
• ヘブライ大学ハダッサ医科大学校 — 消化器学の専門。

科学活動

シボレト博士は肝疾患の研究を行っており、60を超える出版物と100の会議要旨の著者です。

組織への所属

• イスラエル消化器病学会
• アメリカ消化器学会
• ヨーロッパ肝臓研究会議
• アメリカ肝疾患学会。

• 教育
• 1992-1999 - 医学部、テクニオン。
• 専門
• 2000-2005 - インターンシップ、視覚化研究所、テルアビブ・ソラスキー医療センター（イヒロフ）。
• 認識された経験
• 診断放射線学
• サブスペシャリゼーション:
• 2005-2007 - 乳房画像診断、マンモグラフィー研究所、テルアビブ医療センター。
• 追加教育
• 2008 - 乳腺のMRI、パリ、フランスのキュリー研究所医療センターでのインターンシップ。
• 2012 - 先進的な乳房画像技術のトレーニング期間、グスタフ・ルッシー癌センター、ヴィルジュイフ、フランス。
• 2009,2011,2013 - 乳房視覚化に関する更新されたコース。
• 臨床経験
• 2013 - マンモグラフィー部門のディレクター、テルアビブ医療センター。
• 2007 - マッカビHMOの乳房画像診断コンサルタント。
• 2005 - シニア医師、ソラスキー医療センター、テルアビブ。
• 2000-2005 - インターンシップ、視覚化研究所、ソラスキー医療センター、テルアビブ。
• 1999-2000 - インターンシップ、シェバ医療センター。
• 学術経験
• 2010 - 医学生への乳房画像診断トレーニング、臨床年制、画像診断科、テルアビブ大学医学部
• 2013 - 外科研修医の講師、継続教育スクール、医学部、テルアビブ大学。
• 2000-2005 - ソラスキー医療センター、テルアビブ、バル・イラン大学の放射線学講師。
• 労働組合会員
• イスラエル放射線学会
• 乳房画像診断部
• イスラエル医学協会
• 北米放射線学会。
• 特別な関心分野と活動
• 乳房生検および術前MRIガイド下マーキング。
• 自動3D超音波による乳房画像化。
• 非侵襲的ラジオ周波数技術（BLES）を使用した乳房腫瘤の除去。
• 造影剤導入によるマンモグラフィー。
• 分子乳房イメージング、MBI（Molecular Breast Imaging）

ユニバーシティ・プロフ・ドクター ヨハネス・グリサーは、リウマチ学と内科医学のオーストリアの第一人者であり、炎症性関節疾患、自己免疫疾患、結合組織疾患の専門知識で国際的に認められています。 臨床医として、研究者として数十年の経験を持ち、慢性的なリウマチ性疾患の理解と治療の進展に大きく貢献しています。

彼はウィーン大学で医学を学び、1990年代に卒業し、ウィーン医科大学で内科のレジデンシーを修了しました。 キャリアの初期において、彼はリウマチ代用関節炎と全身性自己免疫性疾患の病因に焦点を当て、臨床的な卓越性と科学の厳密さを兼ね備えています。

     1990年代 – 医学研究と内科の専門家トレーニングを完了しました。

     2000年代 – リウマチ学と免疫学を専門とし、リウマチ代用関節炎、ループス、強皮症、血管炎に焦点を当てました。

     2010年代 – ウィーン医科大学でリウマチ学教授に任用され、免疫媒介性炎症性疾患に関する多数の臨床トランスレーショナルリサーチプロジェクトを主導しました。

     現在 – ウィーン プライヴァートクリニークで上級コンサルタントとして勤務し、自己免疫および炎症性関節疾患のための高度な診断および治療オプションを提供しながら、彼の学術および臨床の仕事を続けています。

グリサー教授の研究は、自己免疫性疾患における免疫細胞活性化、炎症バイオマーカー、新規治療ターゲットを探ります。 彼は国際ジャーナルに多数の出版経験があり、ヨーロッパのリウマチ学ネットワークでアクティブな参加者です。

慎重な診断アプローチ、共感、科学的な正確さで知られるグリサー教授は、証拠に基づく医学と専門的なケアを組み合わせています。 彼の仕事はオーストリアやそのほかの国で現代のリウマチ学に影響を及ぼし続けており、複雑なリウマチ性疾患を持つ患者にとって信頼できる専門家とされています。

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Zuhal Cakmak Peksen is a Family Medicine Specialist since 2017. She earned her MD from Çukurova University in 2010. She completed specialty training at Yüzüncü Yıl University between 2013 and 2017. She is currently studying for a bachelor’s degree in Health Management at Anadolu University (2024–present).

She has 15 years of clinical practice (2010–2025) across 8 institutions. Her experience includes research in Family Medicine (2013–2017) and work at several Family Health Centers. Since 2020, she has served at TOKİ Avrupa Family Health Center in Gaziosmanpaşa, Istanbul.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Yan Zhi Ping is the Director of the Radiology Department at Xiamen Humanity Hospital. He graduated from the First Military Medical University. He has authored more than 30 papers. He has edited and contributed to several monographs. He received a Fujian Provincial Third Prize for Science and Technology Progress and two Xiamen Municipal Second Prizes. His expertise includes CT and MRI of the central nervous system, musculoskeletal system, thoracic, and abdominal diseases. He also focuses on cerebral functional imaging. He is skilled in the early diagnosis and differential diagnosis of lung cancer and brain tumors.

Appointments: Standing Committee Member of the Radiology Branch of the Fujian Association of Integrative Medicine. Standing Committee Member of the Fujian Radiological Society. Vice Chairman of the Xiamen Radiological Society. Vice Chairman of the Radiology Branch of the Xiamen Medical Doctor Association. Deputy Director of the Xiamen Radiology Quality Control Center.

Education

Doctor of Medicine (M.D.) degree from Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 2022

Certifications

Certification of Anti-aging and Regenerative Medicine from The American Board of Antiaging and Regenerative Medicine (ABAARM)

Certification of Nutritional Wellness from The American

Naturopathic Certification Board (ANCB)

Clinical Focus

General disease diagnosis and treatment, as well as wellness care

Languages spoken: Thai and English

Dr. Boaz Liberman, MD, is an orthopedic oncologist and sarcoma surgeon for adults and children. He directs the Orthopedic Oncology Unit and serves as Vice Head of Orthopedic Surgery at Sheba Medical Center. His focus is limb-sparing cancer surgery with functional reconstruction. He performs complex joint reconstruction, revision arthroplasty, MRgFUS, and reconstruction after bone metastases.

Education and training: MD, Tel Aviv University. Orthopedic surgery residency, Sheba Medical Center. Fellowships in Adult Reconstruction at Mount Sinai Hospital, Toronto, and in Orthopedic Oncology at Mount Sinai Hospital and Princess Margaret Cancer Centre. He is board-certified in Orthopedic Surgery and in Orthopedic Oncology Surgery. He is a Clinical Instructor at Tel Aviv University. Memberships include the Israel Medical Association, Israel Orthopedic Association, AATB, and EATB. He also serves on national advisory committees. His research covers bone and soft tissue sarcomas, serum markers, imaging-guided therapies, MRI arthrography, and the biomechanics of bone treated with MRgFUS.